ARCHIVES

President’s Cancer Panel Special Commission On Breast Cancer Named

This article is from The Cancer Letter archive.

Vol. 18 No. 17 | April 25, 1992

Download PDF Visit The Full Archive

Related Articles

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980